Dexlansoprazole
Active substance: dexlansoprazole sesquihydrate
CAPSULE, DELAYED RELEASE PELLETS · DEXLANSOPRAZOLE SESQUIHYDRATE 30 mg/1
United StatesActive
Marketing holder: Mylan Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DEXLANSOPRAZOLE SESQUIHYDRATE · 30 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-d252-7c41-89b0-76d6a0c5b7ae,01a1209b-c3c6-7419-a961-a4eba171bea1;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0378-2085
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0378-2085 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0378-2085 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0378-2085 · Verified 2026-10-09 · open in source